| ●Editorial | Fukushima M | 4-5 | Full text | |
| ●＜Clinical Research Risk Management Study Group Open Seminar＞ Achievements of AMED and exponential research and development in Japan: Strategies as a leading country to solve the issues of an aging society Organized by Clinical Research Risk Management Study Group |
7-61 | Abstract | ||
| Our mission: Global data sharing | Suematsu M | 11-24 | ||
| Academia-originated Disruptive Innovations and Prospects for Disease Control | Fukushima M | 25-46 | ||
| Panel Discussion | Suematsu M，Fukushima M （Organized by Clinical Research Risk Management Study Group， Mimura M, Kurihara C， Nabeoka Y, Niikawa Y, Okamoto S） | 47-61 | ||
| ●The Steps to Disease Control: University’s mission to establish an R&D ecosystem Organized by Translational Research Center for Medical Innovation, Foundation for Biomedical Research and Innovation at Kobe | 63-133 | Abstract | ||
| 11-year-efforts and accomplishments from 2007 －Disruptive innovation in Academic Research Organization (ARO)－ | Fukushima M | 67-89 | ||
| A Recommendation | Fukushima M | 90-1 | ||
| The rare disease study support system in Japan To control rare diseases－Facts and foresights of academic medical innovation | Fukushima M，Kimura E | 93-104 | ||
| For the sharp decrease in the social burden of medical expenses, nursing care －Design of the area data utilization hubs and the infrastructure development to provide curative treatment－ | Fukushima M，Kohno K， Kojima S，et al． |
105-15 | ||
| Steps to Disease Control Regenerative medicine for spinal cord injury－Principle, history, fact and foresight | Fukushima M，Omae K | 117-29 | ||
| ECRIN data centre certification given to TRI | 131 | |||
| Orphanet Japan Website: released at TRI | 132-3 | |||
| ●Original | ||||
| Roles of an Academic Research Organization (ARO) in the Investigator-Initiated Development of a Medical Device: A representative case of the TITANBRIDGE® | Nishimura T，Sanuki T， Isono T，et al． |
135-46 | Abstract | |
| ●Symposium Announcement | ||||
| Presidential Symposium in the 40th Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics, 2019 International collaborative research and new trends of research ethics “Declaration of Helsinki: Challenges and new trends ahead of us” Dr. Otmar Kloiber, M.D., Ph.D.， Secretary General, World Medical Association, Inc. “The past, now and future of ethics of international health resarch as a stepping-stone to universal public health care access” Dr. Dirceu Greco, M. D., Ph.D.， Emeritus Professor, Federal University of Minas Gerais |
147-9 | Full text | ||
| ●Instructions for authors［Japanese］＆［English］ | 361-9 | Full text | ||
| ［Electronic publications only］ | ||||
| ●Symposium Announcement | ||||
| Presidential Symposium in the 40th Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics, 2019 International collaborative research and new trends of research ethics “Declaration of Helsinki: Challenges and new trends ahead of us” Dr. Otmar Kloiber, M.D., Ph.D.， Secretary General, World Medical Association, Inc. “The past, now and future of ethics of international health resarch as a stepping-stone to universal public health care access” Dr. Dirceu Greco, M. D., Ph.D.， Emeritus Professor, Federal University of Minas Gerais | 161-3 W1-W3 | Full text | ||